Greenway Greenhouse Cannabis Corporation, a cultivator of high-quality greenhouse cannabis for the Canadian market, has entered into a supply agreement with 4C LABS, a medical cannabis company located in the United Kingdom, focused on providing patients with world class medical cannabis products.
Through the agreement the company expects to supply high-quality, dried flower product to 4C LABS, an importer and distributor of cannabis-based pharmaceuticals in the United Kingdom.
"We have met with many international groups looking for strong, consistent cannabis for medical use, as Canadian cannabis is seen as the gold standard for quality, safety and value. For Greenway, working with international partners opens us up to the fastest growing markets around the world, which should provide better margins than the current Canadian domestic market," said Carl Mastronardi, President of Greenway. "The team at 4C LABS impressed us with their local distribution system and drive to ensure only the best cannabis is used in their supply chain. Our product is perfectly suited to help them deliver on their unique value proposition to UK patients. We are excited about the prospect of seeing the product we put so much hard work into enjoyed by people around the world."
"We are impressed with the capabilities and company culture at Greenway" said Greg Dobbin, CEO of 4C LABS, "Greenway has developed into a premier medical cannabis grower, a result of decades of experience with greenhouse growing. They offer outstanding medical cannabis products at a very competitive price, which the patients of the UK will appreciate. We are excited to add Greenway to the 4C LABS product line."
